Interv Akut Kardiol. 2015;14(3):99-100
Interv Akut Kardiol. 2015;14(3):101
Interv Akut Kardiol. 2015;14(3):102-107
Aim: Retrospective analysis of results of endovascular treatment of complicated aortic dissection type B using thoracic stent grafts (SG) and stents. Material and Methods: We treated 34 patients (7 women, 27 men, mean age 60.4 years) endovascularly due to complicated dissection B of thoracic aorta from February 2001 to August 2014. Indication to treatment was acute rupture of aorta in 6 cases, ischemic complications in 12 cases, early aortic expansion in 10 cases, back pain and refractory hypertension despite full medical therapy in 6 cases. Results: We implanted 49 stent grafts in 34 patients (1.4 SG/patient). To improve perfusion of dissected...
Interv Akut Kardiol. 2015;14(3):109-116
The review-based paper describes the measurement options – clinical (office), ambulatory, home blood pressure measurement including the self-monitoring in patients suffering from hypertension. Next, measuring in pharmacies and telemedicine monitoring approaches are described too. There are also summarized findings of information connected to the validation and control of the technical equipment and principles of approaches to the blood pressure measurement, including the elimination of potential mistakes with the respect of the confounding phenomena. The paper is based on information obtained from relevant publication outputs (articles,...
Interv Akut Kardiol. 2015;14(3):117-119
Our case report describes a patient with stable angina pectoris suffering from a single diseased coronary artery, right coronary artery chronic total occlusion (CTO). Following a primary unsuccessful antegrade recanalization of the occlusion, retrograde recanalization was successfully performed in a second step.
Interv Akut Kardiol. 2015;14(3):120-122
Myokarditida je definována jako zánětlivé onemocnění srdečního svalu, diagnostikované pomocí zavedených histologických, imunologických a imunohistochemických kritérií (1). Je běžně způsobována virem, ale mohou ji rovněž způsobovat bakteriální infekce nebo různé toxiny (2–4). Její přesná incidence není známá, nicméně u celé řady rutinně prováděných pitev mělo příznaky zánětu myokardu 1 až 9 % všech pacientů. U mladých dospělých zodpovídá myokarditida za téměř 20 % všech případů náhlého úmrtí (5). U symptomatických pacientů se myokarditida často projevuje jako akutní srdeční selhání, i když může napodobovat akutní infarkt myokardu nebo tachyarytmii...
Interv Akut Kardiol. 2015;14(3):124-128
Background: The IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) is evaluating the potential benefit for reduction in major cardiovascular (CV) events from the addition of ezetimibe versus placebo to 40 mg/d of simvastatin therapy in patients who present with acute coronary syndromes and have low-density lipoprotein cholesterol (LDL-C) ≤125 mg/dL. Methods: Randomized double blind clinical trial in patiens with acute coronary syndrome and low cholesterol level. The simvastatin monotherapy arm‘s LDL-C target was
Interv Akut Kardiol. 2015;14(3):133-134
Interv Akut Kardiol. 2015;14(3):129-131
This article describes the basic principles of fractional flow reserve. It covers systems to measure the blood pressure inside vessels. It analyses the basic aspects of digitalization and the transfer of signal between senzor and computer. Three commercially produced systems are described.